Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Pharmacol Toxicol ; 24(1): 31, 2023 05 12.
Article in English | MEDLINE | ID: mdl-37173727

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic hepatic disorder. The naturally occurring phytosterol; ß-sitosterol has antiobesogenic and anti-diabetic properties. The purpose of this study was to explore the role of ß-sitosterol in preventing hepatic steatosis induced by a high-fat diet (HFD) in rats. In the current study, to induce NAFLD in the female Wister rats, an HFD was administered to them for 8 weeks. The pathogenic severity of steatosis in rats receiving an HFD diet was dramatically decreased by oral administration of ß-sitosterol. After administering ß-sitosterol to HFD-induced steatosis for three weeks, several oxidative stress-related markers were then assessed. We showed that ß-sitosterol reduced steatosis and the serum levels of triglycerides, transaminases (ALT and AST) and inflammatory markers (IL-1ß and iNOS) compared to HFD-fed rats. Additionally, ß-sitosterol reduced endoplasmic reticulum stress by preventing the overexpression of inositol-requiring enzyme-1 (IRE-1α), X-box binding protein 1(sXBP1) and C/EBP homologous protein (CHOP) genes which, showing a function in the homeostatic regulation of protein folding. Also, it was found that the expression of the lipogenic factors; peroxisome proliferator-activated receptor (PPAR-α), sterol regulatory element binding protein (SREBP-1c) and carnitine palmitoyltransferase-1(CPT-1), which are involved in the regulation of the fatty acid oxidation process, may be regulated by ß-sitosterol. It can be concluded that ß-sitosterol may prevent NAFLD by reducing oxidative stress, endoplasmic reticulum stress and inflammatory responses, which supports the possibility of using ß-sitosterol as an alternative therapy for NAFLD. Together, ß-sitosterol may be an option for NAFLD prevention.


Subject(s)
Non-alcoholic Fatty Liver Disease , Female , Rats , Animals , Non-alcoholic Fatty Liver Disease/drug therapy , Non-alcoholic Fatty Liver Disease/prevention & control , Non-alcoholic Fatty Liver Disease/genetics , Lipid Metabolism , Liver/metabolism , Diet, High-Fat/adverse effects , Rats, Wistar , Inflammation/drug therapy , Inflammation/prevention & control , Inflammation/metabolism
2.
Int J Immunopathol Pharmacol ; 36: 3946320221137435, 2022.
Article in English | MEDLINE | ID: mdl-36319192

ABSTRACT

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is a worldwide health problem with high prevalence and morbidity associated with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and dyslipidemia. Nano-formulation of luteolin with Zn oxide in the form of Lut/ZnO NPs may improve the anti-diabetic property of each alone and ameliorate the insulin resistance thus management of NAFLD. This study aimed to measure the efficiency of Lut/ZnO NPs against insulin resistance coupled with NAFLD and T2DM. METHODS: A diabetic rat model with NAFLD was induced by a high-fat diet and streptozotocin (30 mg/kg I.P). Serum diabetogenic markers levels, lipid profile, and activity of liver enzymes were measured beside liver oxidative stress markers. Moreover, the hepatic expressions of PI3K/AKT/FoxO1/SERBP1c as well as heme oxygenase-1 were measured beside the histopathological examination. RESULTS: Lut/ZnO NPs treatment effectively reduced hyperglycemia, hyperinsulinemia, and ameliorated insulin resistance. Additionally, Lut/ZnO NPs improved the hepatic functions, the antioxidant system, and reduced the oxidative stress markers. Furthermore, the lipid load in the liver, as well as the circulating TG and TC, was minified via the suppression of lipogenesis and gluconeogenesis. Moreover, Lut/ZnO NPs activated the PI3K/AKT signaling pathway, hence inactivating FoxO1, therefore enhancing the hepatic cells' insulin sensitivity. CONCLUSION: Lut/ZnO NPs have a hepatoprotective effect and may relieve the progression of NAFLD by alleviating insulin resistance, ameliorating the antioxidant status, and regulating the insulin signal pathway.


Subject(s)
Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Insulin Resistance , Nanoparticles , Non-alcoholic Fatty Liver Disease , Zinc Oxide , Rats , Animals , Zinc Oxide/metabolism , Zinc Oxide/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Luteolin , Diabetes Mellitus, Type 2/metabolism , Antioxidants/pharmacology , Diabetes Mellitus, Experimental/metabolism , Insulin/metabolism , Liver , Lipids , Nerve Tissue Proteins/metabolism , Nerve Tissue Proteins/pharmacology
3.
Nutr Cancer ; 74(1): 288-298, 2022.
Article in English | MEDLINE | ID: mdl-33511885

ABSTRACT

The present study was undertaken to evaluate the chemopreventive activity of myrtenal, a natural monoterpene, against bladder carcinoma in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) and promoted with γ-ionizing radiation (γ-IRR) as well as to assess the involvement of inflammation, apoptosis and oxidative damage in tumor development. Histopathological examination of rat bladder revealed the presence of noninvasive papillary transitional cell carcinoma (Grade 2) in sections from BBN group indicating the credibility of the applied carcinogenesis model. Myrtenal treatment caused improvement in urinary bladder mucosa with cells more likely in Grade 1. Administration of myrtenal to BBN-treated rats exhibited downregulation in the expressions of COX-2, NF-kB and STAT-3 associated with suppression of inflammatory cytokines levels of TNF-α and IL-6 as well as biomarkers of oxidative damage (MDA & NO). In addition, myrtenal treatment caused a significant increase in caspase-3 activity and Bax/Bcl-2 ratio. Data obtained suggested that the anti-inflammatory effect and the induction of apoptosis contributed largely to the beneficial antitumor effects of myrtenal in rats with BBN/γ-IRR-induced bladder carcinoma. Present findings, in addition to benefits described in other pathologies, indicated myrtenal as a potential adjuvant natural compound for the prevention of tumor progression of bladder cancer.


Subject(s)
Nitrosamines , Urinary Bladder Neoplasms , Animals , Bicyclic Monoterpenes , Butylhydroxybutylnitrosamine/metabolism , Butylhydroxybutylnitrosamine/toxicity , Carcinogenesis , Carcinogens/pharmacology , Nitrosamines/pharmacology , Rats , Urinary Bladder/metabolism , Urinary Bladder/pathology , Urinary Bladder Neoplasms/chemically induced , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/prevention & control
4.
Asian Pac J Cancer Prev ; 21(6): 1709-1716, 2020 Jun 01.
Article in English | MEDLINE | ID: mdl-32592368

ABSTRACT

Combination therapy has been the trendy of care, particularly in cancer remedy, since it is a rational approach to increase response and tolerability and to diminish resistance. Hence, there is a growing interest in combining anticancer drugs to maximizing efficacy with minimum systemic toxicity through the delivery of lower drug doses. Therefore, in the present study, the value of combination between benzethonium chloride (benzo) and endoxan (endo) as anti-tumor drug sensitization of hepatocellular carcinoma HCC treatment were detected both in vitro and in vivo. Crystal violet test was performed to detect the proliferation of HepG2 cells treated with benzo or/and endo. In addition, the HCC rat model was established by diethylnitrosamine (DEN) administration. The antitumor effect was enhanced with the combined treatment of the two drugs, particularly in the group with benzo and endo. The results confirmed that the HCC condition was developed in response to lower expressions of caspase 3 and P53 which, in turn, was due to the overexpression of Bcl-2, and downregulation of cytochrome C. The treatment with benzo combined with endo caused significant activation of caspase-3 mediated apoptotic signals that could be responsible for its anti-HCC potential. Meantime, benzo combined with endo treatments could reduce the hepatocellular carcinogenesis by reducing the expression of MMP-9. Therefore, benzo and endo treatments may be a hopeful therapeutic drug for HCC. Also, more studies are recommended to feat the idea of this research for medical use.
.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Apoptosis , Benzethonium/pharmacology , Carcinoma, Hepatocellular/pathology , Cyclophosphamide/pharmacology , Drug Synergism , Liver Neoplasms/pathology , Animals , Anti-Infective Agents, Local/pharmacology , Antineoplastic Agents, Alkylating/pharmacology , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/metabolism , Cell Proliferation , Drug Therapy, Combination , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/metabolism , Male , Rats , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
5.
J Diet Suppl ; 15(6): 923-938, 2018 Nov 02.
Article in English | MEDLINE | ID: mdl-29336631

ABSTRACT

Radiation protection research receives intense focus due to its significant impact on human health. The present study was undertaken to investigate the protective effect of pretreatment with tomato seed oil (TSO) against gamma radiation-induced damage in rats. Male Wistar rats were divided into four groups: (1) untreated control; (2) TSO-supplemented; (3) gamma-irradiated; (4) TSO-pretreated and gamma-irradiated. Acute exposure of animals to a single gamma radiation dose (6 Gy) induced oxidative stress in major body organs, altered serum lipid homeostasis, significantly increased serum testosterone and sorbitol dehydrogenase levels, and elicited a systemic inflammation as manifested by the induction of serum vascular cell adhesion molecule-1. Oral pretreatment with TSO (1 ml/kg; 3 times/week for 8 weeks) before exposure to gamma radiation protected rats against ionizing radiation-induced oxidative stress, restored lipid homeostasis, and suppressed systemic inflammation. Histological findings of target tissues verified biochemical data. The radioprotective ability of TSO was attributed to its content of phytosterols, policosanol, and antioxidants, including lycopene, ß-carotene, lutein, and tocopherols. TSO is considered a promising radioprotective agent that can be effectively used to protect the body from the damaging effects of harmful radiation.


Subject(s)
Gamma Rays/adverse effects , Plant Oils/administration & dosage , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents , Seeds/chemistry , Solanum lycopersicum , Animals , Antioxidants/pharmacology , Inflammation , Kidney/drug effects , Kidney/pathology , L-Iditol 2-Dehydrogenase/blood , Lipid Peroxidation/drug effects , Lipids/blood , Liver/drug effects , Liver/enzymology , Liver/pathology , Male , Oxidative Stress , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Testis/drug effects , Testis/pathology , Testosterone/blood , Vascular Cell Adhesion Molecule-1/blood
6.
Free Radic Res ; 51(11-12): 943-953, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29069960

ABSTRACT

Cellular exposure to ionising radiation leads to oxidative stress events, which refer to elevated intracellular levels of reactive oxygen species (ROS). The elevated levels of ROS significantly contributed to γ-radiation (IR) induced cytotoxicity. In an attempt to minimise these cytotoxic effects, antioxidant compounds have been identified to counteract radiation- associated toxicities. We mainly aimed to study the protective effect of 4-(4-hydroxy-3-methoxyphenyl)-2-butanone (HMB) on IR-induced nephrotoxicity, whereas it was previously shown to have anti-inflammatory effects in different inflammation models. Animals were treated orally with HMB (25 mg/kg b.wt daily) then performed by whole-body gamma-irradiation of animals with 6 Gy; a single dose applied on the 15th day and animals were sacrificed at the end of the 23rd day. It was found that IR exposure significantly induced renal oxidative injury that accompanied by inflammatory disturbance. Also, NADPH oxidase and iNOS gene expressions were significantly up-regulated, while the mitochondrial enzymes (complex I & II) were significantly down-regulated in IR exposed animals. Additionally, Western immunoblotting analysis of signalling growth factor protein; p38 MAPK was significantly overexpressed. Interestingly, HMB treatment showed statistically significant amelioration in parameters with an improved histological structure upon the IR-induced nephrotoxicity. It can be concluded that modulation of NADPH-oxidase, iNOS and mitochondrial enzymes by HMB might be responsible for the amendment of the antioxidant status and impairment of p38 MAPK signal, thus attenuate the nephrotoxicity induced post IR exposure.


Subject(s)
Gamma Rays/adverse effects , Guaiacol/analogs & derivatives , Kidney Diseases/etiology , Kidney/drug effects , Animals , Guaiacol/pharmacology , Guaiacol/therapeutic use , Kidney Diseases/pathology , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...